SCHEMBL7255658

SCHEMBL7255658

O=Cc1ccccc1-c1cc(-c2ccccc2)nnc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP1 P29466 3/20 0.48
▸ MAOB P27338 3/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ AGTR1 P30556 1/20 0.44
▸ SMARCA2 P51531 1/20 0.41
▸ SMARCA4 P51532 1/20 0.41
▸ PBRM1 Q86U86 1/20 0.41
▸ EIF4E P06730 1/20 0.40
▸ XDH P47989 1/20 0.39
▸ GRM5 P41594 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753088 0.83 CASP1 (0.53) CASP1MAOBSMN1; SMN2NPC1RAB9A
SCHEMBL7256443 0.82 TDP1 (0.40) SMN1; SMN2PKMEIF4EXDHGRM5
SCHEMBL1752831 0.77 SMARCA2 (0.59) CASP1MAOBSMN1; SMN2NPC1RAB9A
SCHEMBL24500388 0.75 MEN1 (0.62) MAOBSMN1; SMN2MAPTAGTR1EIF4E
SCHEMBL29506697 0.72 LMNA (0.52) SMN1; SMN2NPC1RAB9AXDHMEN1
Benzene SCHEMBL28725386 0.72 LMNA (0.52) SMN1; SMN2NPC1RAB9AXDHMEN1
SCHEMBL184258 0.72 LMNA (0.52) SMN1; SMN2NPC1RAB9AXDHMEN1
SCHEMBL96494 0.71 LMNA (0.57) SMN1; SMN2NPC1RAB9AXDHMEN1
Benzene SCHEMBL27923728 0.71 LMNA (0.57) SMN1; SMN2NPC1RAB9AXDHMEN1
SCHEMBL24500394 0.71 MEN1 (0.50) MAOBSMN1; SMN2MAPTXDHMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003080616-A1 PYRAZOLOPYRIDAZINE DERIVATIVES, PROCESS FOR PREPARATION AND USE FOR THE INHIBITION OF GSK-3 GLAXO GROUP LIMITED (GB) 2003-10-02 — — WO disclosed
Send feedback